FURLANUT, Mario
 Distribuzione geografica
Continente #
NA - Nord America 6.508
EU - Europa 1.670
AS - Asia 893
SA - Sud America 115
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 9.200
Nazione #
US - Stati Uniti d'America 6.456
UA - Ucraina 544
SG - Singapore 431
DE - Germania 265
CN - Cina 256
SE - Svezia 187
IT - Italia 174
RU - Federazione Russa 153
FI - Finlandia 140
BR - Brasile 104
IE - Irlanda 95
TR - Turchia 90
CA - Canada 46
KR - Corea 42
GB - Regno Unito 38
IN - India 27
BE - Belgio 20
FR - Francia 16
IR - Iran 14
CZ - Repubblica Ceca 8
HK - Hong Kong 8
NL - Olanda 7
ES - Italia 5
EU - Europa 5
MX - Messico 5
BD - Bangladesh 4
AT - Austria 3
IL - Israele 3
PE - Perù 3
RO - Romania 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
EC - Ecuador 2
JP - Giappone 2
PH - Filippine 2
PT - Portogallo 2
TG - Togo 2
ZA - Sudafrica 2
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 9.200
Città #
Fairfield 879
Ann Arbor 674
Woodbridge 647
Chandler 490
Houston 431
Ashburn 415
Wilmington 351
Seattle 349
Jacksonville 347
Singapore 306
Cambridge 284
Dearborn 212
Boardman 130
Beijing 102
Princeton 98
Dublin 95
Udine 87
Izmir 86
New York 62
Des Moines 58
San Diego 52
Seoul 31
Ottawa 30
Ogden 22
Brussels 20
Munich 18
Nanjing 18
San Mateo 15
Kunming 14
Los Angeles 13
Jinan 12
Falls Church 11
Leawood 11
Guangzhou 10
Norwalk 10
Shanghai 10
Augusta 9
Helsinki 9
Monmouth Junction 9
Mumbai 9
Brno 8
Düsseldorf 8
Hefei 8
Hong Kong 8
Nanchang 8
Santa Clara 8
Naples 7
Trieste 7
Winnipeg 7
Belo Horizonte 6
Hebei 6
San Francisco 6
Boston 5
Brasília 5
Brooklyn 5
Changsha 5
Grafing 5
London 5
Montreal 5
Padova 5
São Paulo 5
Ardabil 4
Bologna 4
Indiana 4
Mexico City 4
Moscow 4
Rome 4
Simi Valley 4
Wenzhou 4
Wuhan 4
Andover 3
Atlanta 3
Chengdu 3
Council Bluffs 3
Dallas 3
Frankfurt am Main 3
Juiz de Fora 3
Lauterbourg 3
Lima region 3
Livorno 3
Portsmouth 3
Rio de Janeiro 3
Saint Petersburg 3
San Sperate 3
Shenyang 3
Tel Aviv 3
Velletri 3
Washington 3
Amsterdam 2
Ankara 2
Auburn Hills 2
Baku 2
Bangalore 2
Bangkok 2
Baotou 2
Betim 2
Colombo 2
Dhaka 2
Dubai 2
Fuzhou 2
Totale 6.682
Nome #
Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring. 160
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. 157
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 152
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 152
Chlorpromazine disposition in relation to age in children 147
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients 140
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 138
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 138
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine. 136
Side effects of imipramine therapy in enuretic children. 130
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 129
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 126
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. 124
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 123
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 122
Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation 122
Determination of tamoxifen and its metabolites in the endometrial tissue of long term treated women 121
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis 120
Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients. 118
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 118
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 117
A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies 116
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions 115
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 114
Effect of fluctuations of blood cyclosporine concentrations on renal function. 112
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis 112
Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients 112
Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures 112
Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. 111
Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy 111
Chronopharmacokinetics of ciclosporin and tacrolimus 110
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 110
Calculating percentage prediction error: a user's note 109
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery 108
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 108
Urinary Pharmacokinetics and Theoretical Pharmacodynamics of Intravenous Levofloxacin in Intensive Care Unit Patients Treated with 500 mg b.i.d. for Ventilator-Associated Pneumonia 108
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective 106
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: A pharmacokinetics/pharmacodynamics-based approach 106
Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose 105
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 105
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 104
A SIMPLE METHOD TO MONITOR PLASMA CONCENTRATIONS OF OXCARBAZEPINE,CARBAMAZEPINE, THEIR MAIN METABOLITES AND LAMOTRIGINE IN EPILEPTIC PATIENTS 104
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 103
Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance 103
Blood concentrations and clinical effect of cyclosporin in psoriasis 101
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 101
Pharmacology of ifosfamide 100
Acute oxcarbazepine, benazepril and hydrochlorothiazide overdose with alcohol 100
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin 99
A simple and sensitive HPLC method ti monitor serum and synovial fluid concnetrations of ketorolac in reumathologic patients 98
Pharmacokinetic-pharmacodynamic aspecte of antimicrobial prophylaxis with teisoplanin in patients undergoing major vascular surgery 98
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients 98
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function? 96
Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation 95
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose 95
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy 95
Imipramine pharmacokinetics in depressed geriatric patients 93
MEGX disposition in critically-ill trauma patients: Subsequent assessments during the first week following trauma 93
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy 91
TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient 91
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients 90
Fluoxetine disposition in patients suffering from chronic hepatitis C treated with interferon alpha 90
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease 89
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients 89
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration 88
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients 88
Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis 88
Isoniazid and its hydrazine metabolite in patients with tuberculosis 87
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association 83
AM and PM C2 monitoring of cyclosporine in liver transplant recipients 83
Antimicrobial agents in elective surgery: Prophylaxis or "early therapy"? 82
CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR) 79
Oral gabapentin disposition in patients with epilepsy after a high-protein meal 78
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods 76
Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients? 75
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 74
Systemic vancomycin overexposure in a patient with spinal cord injury who had staphylococcal sepsis and Clostridium difficile colitis 72
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable 72
Nicotine and cotinine plasma concentrations: Useful markers to optimize nicotine replacement therapy in smokers 68
CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA 68
Preliminary observations on serum concentrations of tamoxifen and its main metabolites in patients with breast cancer 67
Tamoxifen and its main metabolites serum and tissue concentration in breast cancer women 66
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man 66
Pharmacokinetic aspects of levofloxacin 500 mg once-daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections 66
Oral and intravenous disposition of cyclosporine in psoriatic patients. 65
Un caso di encefalite da Mycoplasma pneumoniae trattato con levofloxacina 65
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers 62
Monitoraggio del Gabapentine e della Lamotrigina in pazienti con crisi parziali complesse 57
FARMACOLOGIA CLINICA DELL'ENURESI PRIMARIA 56
Farmacologia generale e clinica per le lauree sanitarie - III Edizione - Ed. Piccin 50
Personalization of antimicrobial dosing regimens: Indicators of performance 50
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases 50
Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages 49
Variability in the metabolism of levodopa and clinical implications 46
Farmacologia - Principi e applicazioni 44
Farmacologia generale e clinica per le lauree triennali 42
Farmacologia generale e clinica per le lauree sanitarie - II edizione 42
Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients 36
Totale 9.436
Categoria #
all - tutte 33.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020203 0 0 0 0 0 0 0 0 0 0 37 166
2020/20211.279 52 162 21 166 67 157 48 137 173 49 181 66
2021/2022941 40 68 47 89 48 50 43 42 15 154 209 136
2022/20231.021 112 90 18 127 132 276 0 74 130 13 20 29
2023/2024319 55 23 7 5 60 72 6 19 36 6 2 28
2024/20251.161 40 110 104 45 73 87 89 107 139 117 250 0
Totale 9.436